Two Sigma Investments, LP Clovis Oncology, Inc. Call Options Transaction History

Two Sigma Investments, LP

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $3.48 Million - $5.1 Million	-60,300 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $4.05 Million - $5.11 Million	60,300	60,300 $4.97 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.